Oliver Dolan
Fortuna: 238 545 $ al 30/06/2026
Fortuna: 238 545 $ al 30/06/2026
Oliver Dolan currently works at Korro Bio, Inc., as Chief Accounting Officer & Senior VP-Finance from 2025.
Mr. Dolan also formerly worked at Unity Biotechnology, Inc., as Vice President-Accounting, Tax & Treasury from 2020 to 2023.
Mr. Dolan received his undergraduate degree from University College Dublin and Masters Business Admin degree from MIT Sloan School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,19 % | 16/06/2026 | 18.099 ( 0,19 % ) | 238 545 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Comptroller/Controller/Auditor | 01/12/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
University College Dublin
University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Unity Biotechnology, Inc.
Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.